Preparation method of benzo 1, 3-dioxin-4 ketone acetal compound
A compound and benzo-based technology are applied in the field of preparation of benzo-1,3-dioxin-4 ketone acetal compounds to achieve the effects of wide substrate range, efficient green synthesis and simple operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] Example 1: Synthesis of 2-(2-carbonylpropyl)-2-phenyl-4-hydrogen-benzo[d][1,3]dioxin-4-one:
[0035] The structural formula of this example is as follows:
[0036]
[0037] To a dichloromethane solution (2 mL) of salicylic acid (0.3 mmol) and 4-phenyl-3-butyn-2-one (0.3 mmol), tetrahydropyrrole (10 mol%) was added dropwise under stirring conditions, and room temperature (25°C) to react overnight. The reaction solution was spin-dried and purified by column chromatography to obtain the target product 2-(2-carbonylpropyl)-2-phenyl-4-hydrogen-benzo[d][1,3]dioxin-4-one: 77.08 mg, yield: 91%, yellow oily liquid. 1 H NMR (400 MHz, CDCl 3 )δ: 7.81 (dd, J=7.8, 1.6Hz, 1H), 7.52 (ddd, J=7.6, 7.1, 1.5Hz, 3H), 7.32 (ddd, J=9.7, 5.5, 2.4Hz, 3H), 7.12 (d,J=8.3Hz, 1H),7.07–6.99(m,1H),3.38–3.20(m,2H),2.32(s,3H). 13 C NMR (101 MHz, CDCl 3 )δ:202.39,160.47,155.93,138.59,136.70,129.84,129.48,128.83,126.30,123.23,117.40,114.61,105.60,55.32,31.85. HR-MS: C 17 h 14 o 4 ,[M+Na] + ...
Embodiment 2
[0038] Example 2: Synthesis of 7-bromo-2-(2-carbonylpropyl)-2-phenyl-4-hydrogen-benzo[d][1,3]dioxin-4-one
[0039]
[0040] To a methanol solution (2 mL) of 4-bromosalicylic acid (0.3 mmol) and 4-phenyl-3-butyn-2-one (0.3 mmol), morpholine (20 mol%) was added dropwise with stirring, React overnight at room temperature (25°C). The reaction solution was spin-dried and purified by column chromatography to obtain the target product 7-bromo-2-(2-carbonylpropyl)-2-phenyl-4-hydrogen-benzo[d][1,3]dioxin- 4-Keto: 80.19 mg, yield: 74%, yellow oily liquid. 1 H NMR (400MHz, CDCl3) δ: 7.68 (d, J = 8.4Hz, 1H), 7.49 (dd, J = 7.8, 1.5Hz, 2H), 7.39–7.32 (m, 4H), 7.19 (dd, J = 8.4,1.7Hz,1H),3.28(d,J=3.2Hz,2H),2.31(s,3H). 13 C NMR(101MHz,CDCl3)δ:201.91,159.81,156.20,138.12,131.13,130.94,129.72,128.99,126.90,126.24,120.73,113.47,106.07,55.04,31.84.HR-MS:C17 +, Calcd.: 382.9889, Found: 382.9884.
Embodiment 3
[0041] Example 3: Synthesis of 7-methyl-2-(2-carbonylpropyl)-2-phenyl-4-hydrogen-benzo[d][1,3]dioxin-4-one
[0042]
[0043] To a solution (2 mL) of 4-methylsalicylic acid (0.3 mmol) and 4-phenyl-3-butyn-2-one (0.3 mmol) in tetrahydrofuran (2 mL), piperidine (5 mol%) was added dropwise with stirring, React overnight at room temperature (25°C). The reaction solution was spin-dried and purified by column chromatography to obtain the target product 7-methyl-2-(2-carbonylpropyl)-2-phenyl-4-hydrogen-benzo[d][1,3]dioxin -4-Kone: 66.62 mg, yield: 75%, colorless oily liquid. 1 H NMR (400MHz, CDCl3) δ: 7.73 (dd, J=8.2, 0.7Hz, 1H), 7.54–7.48 (m, 2H), 7.37–7.29 (m, 3H), 6.62–6.52 (m, 2H), 3.86(s,3H),3.25(q,J=14.5Hz,2H),2.32(s,3H). 13 C NMR (101MHz, CDCl3) δ: 202.62, 166.49, 160.32, 157.83, 138.82, 131.44, 129.42, 128.82, 126.11, 110.85, 107.23, 105.54, 101.31, 55.83, 565.39HR-31.87. Na] + ,Calcd.:319.0941,Found:319.0939
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


